CLINICAL STUDIES ON TA-058 IN THE TREATMENT OF RESPIRATORY TRACT INFECTIONS
1984 Volume 32 Issue Supplement2 Pages 215-218
Details
1984 Volume 32 Issue Supplement2 Pages 215-218
Clinical investigations were performed on TA-058, a newly synthetic penicillin.
TA-058 was administered to 10 cases of respiratory tract infections, at daily dose 2.0g for 5-14 days.
Clinical effectiveness of TA-058 was excellent in two cases and good in 8 cases (efficiency 100%).
Bacteriological effectiveness was good (87.5%) including 4 cases of Klebsiella sp.
Side effect with TA-058 was not observed.
